December 12, 2025

AbCellera Biologics Inc. (ABCL) Stock Analysis: Navigating the Biotech Landscape with a 162.92% Potential Upside

AbCellera Biologics Inc. (NASDAQ: ABCL), a Vancouver-based biotechnology firm, is making waves in the healthcare sector. Specializing in the discovery and development of antibody-based medicines, AbCellera’s..

Maravai LifeSciences (MRVI): Navigating Challenges with Strategic Focus in Biotech

Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) stands as a noteworthy participant in the biotechnology sector, currently commanding a market capitalization of $1.36 billion. Despite recent hurdles,..

CureVac N.V. (CVAC) Stock Analysis: Navigating the Biotech Frontier with a 5.58% Potential Upside

CureVac N.V. (CVAC), a pioneering entity in the biotechnology sector, stands at the forefront of mRNA technology, crafting innovative solutions for a range of medical challenges...

Pharvaris N.V. (PHVS) Stock Analysis: Exploring a Potential 92.91% Upside in Biotech

As the biotechnology sector continues to capture investor attention, Pharvaris N.V. (NASDAQ: PHVS) stands out with a compelling potential upside of 92.91%. Headquartered in Zug, Switzerland,..

AMN Healthcare Services Inc (AMN): Analyst Consensus Highlights 27.32% Potential Upside

AMN Healthcare Services Inc (NYSE: AMN), a key player in the medical care facilities sector, is drawing significant attention due to its strategic positioning and unique..

Arcus Biosciences (RCUS) Stock Analysis: Exploring a 32% Potential Upside Amid Promising Cancer Therapies

Arcus Biosciences, Inc. (NASDAQ: RCUS), a burgeoning player in the biotechnology sector, has captivated investor interest due to its innovative approach to cancer therapy. This Hayward,..

Syndax Pharmaceuticals (SNDX) Stock Analysis: Exploring a 92.59% Potential Upside in the Biotech Sector

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX), a leading player in the biotechnology sector, is capturing investor attention with its promising portfolio of cancer-focused therapies and an impressive..

Fulgent Genetics, Inc. (FLGT) Stock Analysis: Exploring a 24.41% Potential Upside in the Diagnostics Sector

As Fulgent Genetics, Inc. (NASDAQ: FLGT) navigates the competitive landscape of the Diagnostics & Research industry, investors are keenly observing its performance metrics and future potential...

Weave Communications, Inc. (WEAV) Stock Analysis: A 47.54% Potential Upside Beckons Investors

Weave Communications, Inc. (NASDAQ: WEAV) is carving out a niche in the Healthcare sector, specifically within Health Information Services. Headquartered in Lehi, Utah, the company is..

Gyre Therapeutics, Inc. (GYRE) Stock Analysis: A Promising 128% Upside in Biotech Innovation

Investors with an appetite for biotechnology stocks may find Gyre Therapeutics, Inc. (NASDAQ: GYRE) an intriguing opportunity, as the company sits at the intersection of innovation..

Praxis Precision Medicines, Inc (PRAX) Stock Analysis: Exploring the 44% Upside Potential

Praxis Precision Medicines, Inc (NASDAQ: PRAX), a Boston-based biotechnology firm, is gaining traction among investors with its promising pipeline focused on central nervous system (CNS) disorders...

GH Research PLC (GHRS) Stock Analysis: A Promising Biotech with 120% Upside Potential

GH Research PLC (NASDAQ: GHRS), a Dublin-based clinical-stage biopharmaceutical firm, is capturing significant attention in the healthcare sector, particularly within the biotechnology industry. Specializing in innovative..

SI-BONE, Inc. (SIBN) Stock Analysis: Exploring a 34% Potential Upside with Robust Analyst Ratings

SI-BONE, Inc. (NASDAQ: SIBN) stands at the forefront of the healthcare sector, specifically in the medical devices industry. This Santa Clara, California-based company specializes in innovative..

Zymeworks Inc. (ZYME): Analyst Consensus Reveals a Strong 38% Upside Potential for Investors

Zymeworks Inc. (NASDAQ: ZYME), a clinical-stage biotechnology company, is capturing investor attention with its promising pipeline and robust revenue growth. Specializing in biotherapeutics for cancer, autoimmune,..

InMode Ltd. (INMD) Stock Analysis: Unveiling a 16.26% Potential Upside in the Aesthetic Medical Device Sector

InMode Ltd. (NASDAQ: INMD), a notable player in the healthcare sector focusing on medical devices, has been garnering attention due to its innovative approach in the..

Nuvation Bio Inc. (NUVB) Stock Analysis: 36% Potential Upside with Promising Oncology Pipeline

Nuvation Bio Inc. (NASDAQ: NUVB) is a name gaining traction among biotechnology investors, particularly those focused on oncology. With a market capitalization of $2.84 billion, this..

Spyre Therapeutics (SYRE) Stock Analysis: A Biotech Gem with 55.95% Upside Potential

Spyre Therapeutics, Inc. (NASDAQ: SYRE) is making significant waves in the biotechnology sector, particularly for investors looking to capitalize on its potential growth in the inflammatory..

CorMedix Inc. (CRMD) Stock Analysis: A Potential 61.84% Upside with Innovative Healthcare Solutions

In the ever-evolving world of biotechnology, CorMedix Inc. (NASDAQ: CRMD) is capturing investor attention with its promising growth metrics and a compelling potential upside of 61.84%...

Phibro Animal Health Corporation (PAHC) Stock Analysis: Revenue Growth and Strategic Positioning in the Healthcare Sector

Phibro Animal Health Corporation (NASDAQ: PAHC) has emerged as a noteworthy player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With..

STAAR Surgical Company (STAA) Investor Outlook: Navigating Growth in the Medical Instruments Sector

STAAR Surgical Company (NASDAQ: STAA), a key player in the medical instruments and supplies industry, presents a compelling opportunity for investors keen on the healthcare sector...

Search

Funds

December 12, 2025

Search

Funds

December 12, 2025

FTSE 100

Funds